NASDAQ:NATR Nature's Sunshine Products (NATR) Stock Price, News & Analysis → SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad) Free NATR Stock Alerts $19.77 +0.36 (+1.85%) (As of 04/23/2024 ET) Add Compare Share Share Today's Range$19.40▼$19.8350-Day Range$17.20▼$20.8752-Week Range$10.06▼$21.72Volume25,044 shsAverage Volume50,760 shsMarket Capitalization$372.07 millionP/E Ratio25.68Dividend YieldN/APrice Target$24.00 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Get Nature's Sunshine Products alerts: Email Address Nature's Sunshine Products MarketRank™ Stock AnalysisAnalyst RatingBuy3.00 Rating ScoreUpside/Downside21.4% Upside$24.00 Price TargetShort InterestHealthy0.60% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment-1.17Based on 3 Articles This WeekInsider TradingN/AProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.1.71 out of 5 starsMedical Sector612th out of 909 stocksPharmaceutical Preparations Industry278th out of 425 stocks 2.5 Analyst's Opinion Consensus RatingNature's Sunshine Products has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.Amount of Analyst CoverageNature's Sunshine Products has only been the subject of 1 research reports in the past 90 days. Previous Next 5.0 Short Interest Percentage of Shares Shorted0.60% of the float of Nature's Sunshine Products has been sold short.Short Interest Ratio / Days to CoverNature's Sunshine Products has a short interest ratio ("days to cover") of 1.7, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Nature's Sunshine Products has recently decreased by 8.91%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldNature's Sunshine Products does not currently pay a dividend.Dividend GrowthNature's Sunshine Products does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for NATR. Previous Next 0.5 News and Social Media Coverage News SentimentNature's Sunshine Products has a news sentiment score of -1.17. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.46 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 3 news articles for Nature's Sunshine Products this week, compared to 1 article on an average week.Search InterestOnly 2 people have searched for NATR on MarketBeat in the last 30 days. This is a decrease of -75% compared to the previous 30 days.MarketBeat FollowsOnly 2 people have added Nature's Sunshine Products to their MarketBeat watchlist in the last 30 days. This is a decrease of -71% compared to the previous 30 days. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Nature's Sunshine Products insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 4.90% of the stock of Nature's Sunshine Products is held by insiders.Percentage Held by Institutions79.40% of the stock of Nature's Sunshine Products is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 1.3 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Nature's Sunshine Products is 25.68, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 147.08.Price to Earnings Ratio vs. SectorThe P/E ratio of Nature's Sunshine Products is 25.68, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 261.58.Price to Book Value per Share RatioNature's Sunshine Products has a P/B Ratio of 2.36. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad Crypto 101 MediaSHOCKING Crypto Leak…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. About Nature's Sunshine Products Stock (NASDAQ:NATR)Nature's Sunshine Products, Inc., a natural health and wellness company, manufactures and sells nutritional and personal care products in Asia, Europe, North America, Latin America, and internationally. It offers general health products related to blood sugar support, bone health, cellular health, cognitive function, joint health, mood, sexual health, sleep, sports and energy, and vision. The company also provides immunity, cardiovascular, and digestive products; and personal care products, such as oils and lotions, aloe vera gels, herbal shampoos, herbal skin treatment, toothpaste, and skin cleansers, as well as weight management products. It offers its products under the Nature's Sunshine and Synergy WorldWide brands through a sales force of independent consultants. Nature's Sunshine Products, Inc. was founded in 1972 and is headquartered in Lehi, Utah.Read More NATR Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart NATR Stock News HeadlinesApril 23, 2024 | finance.yahoo.comNature’s Sunshine Sets First Quarter 2024 Conference Call for Tuesday, May 7, 2024, at 5:00 p.m. ETApril 23, 2024 | globenewswire.comNature's Sunshine Sets First Quarter 2024 Conference Call for Tuesday, May 7, 2024, at 5:00 p.m. ETApril 24, 2024 | Crypto 101 Media (Ad)SHOCKING Crypto Leak…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. April 21, 2024 | finance.yahoo.comThose who invested in Nature's Sunshine Products (NASDAQ:NATR) five years ago are up 126%April 4, 2024 | finance.yahoo.comNature's Sunshine Products, Inc.'s (NASDAQ:NATR) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?March 15, 2024 | finance.yahoo.comNature's Sunshine Products, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their PredictionsMarch 14, 2024 | marketwatch.comNature's Sunshine Shares Touch 52-Week High After 4Q UpdateMarch 13, 2024 | finance.yahoo.comWhy Nature's Sunshine (NATR) Stock Is Up TodayApril 24, 2024 | Crypto 101 Media (Ad)SHOCKING Crypto Leak…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. March 13, 2024 | finanznachrichten.deNature's Sunshine Products, Inc.: Nature's Sunshine Reports Strong Fourth Quarter and Full Year 2023 Financial ResultsMarch 12, 2024 | finance.yahoo.comNature's Sunshine (NASDAQ:NATR) Misses Q4 Sales TargetsMarch 12, 2024 | gurufocus.comNature's Sunshine Products Inc (NATR) Reports Significant Growth in Q4 and Full Year 2023 EarningsMarch 12, 2024 | globenewswire.comNature's Sunshine Reports Strong Fourth Quarter and Full Year 2023 Financial ResultsMarch 11, 2024 | benzinga.comPreview: Natures Sunshine Products's EarningsMarch 11, 2024 | finance.yahoo.comNature's Sunshine (NATR) Q4 Earnings: What To ExpectFebruary 20, 2024 | finance.yahoo.comNature’s Sunshine Sets Fourth Quarter and Full Year 2023 Conference Call for Tuesday, March 12, 2024, at 5:00 p.m. ETFebruary 20, 2024 | globenewswire.comNature's Sunshine Sets Fourth Quarter and Full Year 2023 Conference Call for Tuesday, March 12, 2024, at 5:00 p.m. ETFebruary 6, 2024 | finance.yahoo.comIs There Now An Opportunity In Nature's Sunshine Products, Inc. (NASDAQ:NATR)?January 31, 2024 | seekingalpha.comNature's Sunshine Products: Unconvincing Trajectory Despite ImprovementsJanuary 2, 2024 | finance.yahoo.comNature’s Sunshine Announces Participation at the 26th Annual Needham Growth Conference on January 19, 2024December 21, 2023 | finance.yahoo.comNature's Sunshine Products, Inc. (NASDAQ:NATR) is definitely on the radar of institutional investors who own 39% of the companyDecember 19, 2023 | finance.yahoo.comNature’s Sunshine Recognized with Best Company Culture AwardDecember 12, 2023 | benzinga.comNatures Sunshine Products Stock (NASDAQ:NATR), Quotes and News SummaryNovember 27, 2023 | msn.comNature`s Sunshine Products (NATR) Price Target Increased by 10.26% to 21.93November 23, 2023 | finance.yahoo.comThe Return Trends At Nature's Sunshine Products (NASDAQ:NATR) Look PromisingNovember 9, 2023 | finance.yahoo.comInvesting in Nature's Sunshine Products (NASDAQ:NATR) a year ago would have delivered you a 108% gainNovember 8, 2023 | morningstar.comNatures Sunshine Products Inc NATRSee More Headlines Receive NATR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Nature's Sunshine Products and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings3/12/2024Today4/24/2024Next Earnings (Estimated)5/14/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical preparations Sub-IndustryPersonal Products Current SymbolNASDAQ:NATR CUSIP63902710 CIK275053 Webwww.naturessunshine.com Phone(801) 341-7900Fax801-342-4305Employees814Year FoundedN/APrice Target and Rating Average Stock Price Target$24.00 High Stock Price Target$24.00 Low Stock Price Target$24.00 Potential Upside/Downside+21.4%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)$0.77 Trailing P/E Ratio25.68 Forward P/E RatioN/A P/E GrowthN/ANet Income$15.08 million Net Margins3.39% Pretax Margin4.54% Return on Equity12.25% Return on Assets7.75% Debt Debt-to-Equity RatioN/A Current Ratio2.16 Quick Ratio1.29 Sales & Book Value Annual Sales$445.32 million Price / Sales0.84 Cash Flow$1.64 per share Price / Cash Flow12.09 Book Value$8.36 per share Price / Book2.36Miscellaneous Outstanding Shares18,820,000Free Float17,897,000Market Cap$372.07 million OptionableOptionable Beta0.82 The Best High-Yield Dividend Stocks for 2024Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.Get This Free Report Key ExecutivesMr. Terrence O. Moorehead (Age 60)President, CEO & Director Comp: $2.12MMr. L. Shane Jones (Age 53)Executive VP, CFO & Treasurer Comp: $1.01MMr. Martin Gonzalez (Age 54)Executive Vice President of Global Supply Chain Operations Comp: $690.73kTrent McCauslandExecutive Director, Head of Operations & COOMr. Nathan G. Brower (Age 43)Executive VP, General Counsel & Secretary Ms. Sarah Crockett (Age 41)Global Chief Marketing Officer Ms. Tracee Comstock (Age 57)Vice President of Human Resources Mr. Bryant J. Yates (Age 51)Executive VP & President of Europe Comp: $496.15kMr. Daniel C. Norman (Age 49)Executive VP & President of Asia/Pacific (APAC) Comp: $574.31kMr. Kevin R. Herbert (Age 57)Executive VP & President of North America More ExecutivesKey CompetitorsVeruNASDAQ:VERUAtai Life SciencesNASDAQ:ATAIFibroBiologicsNASDAQ:FBLGEsperion TherapeuticsNASDAQ:ESPRAlto NeuroscienceNYSE:ANROView All CompetitorsInsiders & InstitutionsWasatch Advisors LPBought 88,433 shares on 4/18/2024Ownership: 2.753%Wasatch Advisors LPBought 429,728 shares on 2/14/2024Ownership: 2.252%Tower Research Capital LLC TRCBought 3,343 shares on 2/13/2024Ownership: 0.022%Tieton Capital Management LLCSold 3,290 shares on 2/9/2024Ownership: 0.510%Trexquant Investment LPBought 12,567 shares on 2/9/2024Ownership: 0.066%View All Insider TransactionsView All Institutional Transactions NATR Stock Analysis - Frequently Asked Questions Should I buy or sell Nature's Sunshine Products stock right now? 1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Nature's Sunshine Products in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" NATR shares. View NATR analyst ratings or view top-rated stocks. What is Nature's Sunshine Products' stock price target for 2024? 1 analysts have issued 12 month price objectives for Nature's Sunshine Products' shares. Their NATR share price targets range from $24.00 to $24.00. On average, they anticipate the company's share price to reach $24.00 in the next twelve months. This suggests a possible upside of 21.4% from the stock's current price. View analysts price targets for NATR or view top-rated stocks among Wall Street analysts. How have NATR shares performed in 2024? Nature's Sunshine Products' stock was trading at $17.29 at the start of the year. Since then, NATR shares have increased by 14.3% and is now trading at $19.77. View the best growth stocks for 2024 here. When is Nature's Sunshine Products' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 14th 2024. View our NATR earnings forecast. How were Nature's Sunshine Products' earnings last quarter? Nature's Sunshine Products, Inc. (NASDAQ:NATR) released its earnings results on Tuesday, March, 12th. The company reported $0.45 earnings per share for the quarter. The business had revenue of $108.94 million for the quarter. Nature's Sunshine Products had a trailing twelve-month return on equity of 12.25% and a net margin of 3.39%. What guidance has Nature's Sunshine Products issued on next quarter's earnings? Nature's Sunshine Products issued an update on its FY 2024 earnings guidance on Tuesday, March, 12th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $455.0 million-$480.0 million, compared to the consensus revenue estimate of $464.3 million. What is Terrence Moorehead's approval rating as Nature's Sunshine Products' CEO? 13 employees have rated Nature's Sunshine Products Chief Executive Officer Terrence Moorehead on Glassdoor.com. Terrence Moorehead has an approval rating of 86% among the company's employees. What other stocks do shareholders of Nature's Sunshine Products own? Based on aggregate information from My MarketBeat watchlists, some companies that other Nature's Sunshine Products investors own include Amicus Therapeutics (FOLD), Gilead Sciences (GILD), Pfizer (PFE), AT&T (T), AbbVie (ABBV), Akorn (AKRX), Bausch Health Companies (BHC), Catalyst Pharmaceuticals (CPRX), Exelixis (EXEL) and Global Blood Therapeutics (GBT). Who are Nature's Sunshine Products' major shareholders? Nature's Sunshine Products' stock is owned by a variety of retail and institutional investors. Top institutional investors include Wasatch Advisors LP (2.75%). Insiders that own company stock include Bryant J Yates, Daniel C Norman, Nathan G Brower and Wynnefield Partners Small Cap. View institutional ownership trends. How do I buy shares of Nature's Sunshine Products? Shares of NATR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:NATR) was last updated on 4/24/2024 by MarketBeat.com Staff From Our Partnerstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencySHOCKING Crypto Leak…Crypto 101 MediaYour Money is Not SafeAmerican AlternativeDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsGlobal crypto currency reset (41 major banks signed up)Stansberry ResearchDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingMan Who Predicted 2008: “This Will be Worse.”AltimetryEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest Metals Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nature's Sunshine Products, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.